S&P 500   4,589.17 (+0.49%)
DOW   34,548.95 (+0.19%)
QQQ   395.67 (+0.47%)
AAPL   169.07 (+2.28%)
MSFT   335.56 (+1.50%)
FB   317.61 (-2.11%)
GOOGL   2,874.86 (+1.30%)
AMZN   3,500.35 (-0.19%)
TSLA   1,138.90 (-0.51%)
NVDA   323.38 (-1.03%)
BABA   125.10 (-1.91%)
NIO   39.62 (+1.25%)
CGC   10.34 (-3.45%)
AMD   154.45 (-2.48%)
GE   95.38 (+0.41%)
MU   87.61 (+4.30%)
T   22.54 (-1.27%)
F   20.05 (+4.48%)
DIS   144.86 (-0.03%)
PFE   54.53 (+1.49%)
ACB   6.22 (-3.12%)
AMC   32.43 (-4.45%)
BA   193.84 (-2.03%)
S&P 500   4,589.17 (+0.49%)
DOW   34,548.95 (+0.19%)
QQQ   395.67 (+0.47%)
AAPL   169.07 (+2.28%)
MSFT   335.56 (+1.50%)
FB   317.61 (-2.11%)
GOOGL   2,874.86 (+1.30%)
AMZN   3,500.35 (-0.19%)
TSLA   1,138.90 (-0.51%)
NVDA   323.38 (-1.03%)
BABA   125.10 (-1.91%)
NIO   39.62 (+1.25%)
CGC   10.34 (-3.45%)
AMD   154.45 (-2.48%)
GE   95.38 (+0.41%)
MU   87.61 (+4.30%)
T   22.54 (-1.27%)
F   20.05 (+4.48%)
DIS   144.86 (-0.03%)
PFE   54.53 (+1.49%)
ACB   6.22 (-3.12%)
AMC   32.43 (-4.45%)
BA   193.84 (-2.03%)
S&P 500   4,589.17 (+0.49%)
DOW   34,548.95 (+0.19%)
QQQ   395.67 (+0.47%)
AAPL   169.07 (+2.28%)
MSFT   335.56 (+1.50%)
FB   317.61 (-2.11%)
GOOGL   2,874.86 (+1.30%)
AMZN   3,500.35 (-0.19%)
TSLA   1,138.90 (-0.51%)
NVDA   323.38 (-1.03%)
BABA   125.10 (-1.91%)
NIO   39.62 (+1.25%)
CGC   10.34 (-3.45%)
AMD   154.45 (-2.48%)
GE   95.38 (+0.41%)
MU   87.61 (+4.30%)
T   22.54 (-1.27%)
F   20.05 (+4.48%)
DIS   144.86 (-0.03%)
PFE   54.53 (+1.49%)
ACB   6.22 (-3.12%)
AMC   32.43 (-4.45%)
BA   193.84 (-2.03%)
S&P 500   4,589.17 (+0.49%)
DOW   34,548.95 (+0.19%)
QQQ   395.67 (+0.47%)
AAPL   169.07 (+2.28%)
MSFT   335.56 (+1.50%)
FB   317.61 (-2.11%)
GOOGL   2,874.86 (+1.30%)
AMZN   3,500.35 (-0.19%)
TSLA   1,138.90 (-0.51%)
NVDA   323.38 (-1.03%)
BABA   125.10 (-1.91%)
NIO   39.62 (+1.25%)
CGC   10.34 (-3.45%)
AMD   154.45 (-2.48%)
GE   95.38 (+0.41%)
MU   87.61 (+4.30%)
T   22.54 (-1.27%)
F   20.05 (+4.48%)
DIS   144.86 (-0.03%)
PFE   54.53 (+1.49%)
ACB   6.22 (-3.12%)
AMC   32.43 (-4.45%)
BA   193.84 (-2.03%)
NYSE:DNMR

Danimer Scientific Stock Forecast, Price & News

$12.48
-0.86 (-6.45%)
(As of 12/1/2021 01:39 PM ET)
Add
Compare
Today's Range
$12.39
$13.68
50-Day Range
$13.34
$19.98
52-Week Range
$12.00
$66.30
Volume
75,529 shs
Average Volume
2.46 million shs
Market Capitalization
$1.25 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-0.45
30 days | 90 days | 365 days | Advanced Chart
Receive DNMR News and Ratings via Email

Sign-up to receive the latest news and ratings for Danimer Scientific and its competitors with MarketBeat's FREE daily newsletter.


Danimer Scientific logo

About Danimer Scientific

Danimer Scientific, Inc., a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petrochemical-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including water bottles, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company offers its products to manufacturers in the plastics industry. Danimer Scientific, Inc. was incorporated in 2004 and is headquartered in Bainbridge, Georgia.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Plastics materials & resins
Sub-Industry
N/A
Fax
N/A
Employees
190
Year Founded
N/A

Sales & Book Value

Annual Sales
$47.33 million
Book Value
$4.21 per share

Profitability

Net Income
$-8.85 million
Net Margins
-102.95%
Pretax Margin
-117.47%

Debt

Price-To-Earnings

Miscellaneous

Free Float
85,393,000
Market Cap
$1.25 billion
Optionable
Not Optionable

Company Calendar

Today
12/01/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
4/04/2022

MarketRank

Overall MarketRank

2.04 out of 5 stars

Industrial Products Sector

127th out of 246 stocks

Plastics Materials & Resins Industry

13th out of 16 stocks

Analyst Opinion: 3.5Community Rank: 3.6Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -












Danimer Scientific (NYSE:DNMR) Frequently Asked Questions

Is Danimer Scientific a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Danimer Scientific in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Danimer Scientific stock.
View analyst ratings for Danimer Scientific
or view top-rated stocks.

When is Danimer Scientific's next earnings date?

Danimer Scientific is scheduled to release its next quarterly earnings announcement on Monday, April 4th 2022.
View our earnings forecast for Danimer Scientific
.

What price target have analysts set for DNMR?

2 analysts have issued 12-month price targets for Danimer Scientific's stock. Their forecasts range from $21.00 to $30.00. On average, they anticipate Danimer Scientific's stock price to reach $25.50 in the next twelve months. This suggests a possible upside of 104.3% from the stock's current price.
View analysts' price targets for Danimer Scientific
or view top-rated stocks among Wall Street analysts.

Who are Danimer Scientific's key executives?

Danimer Scientific's management team includes the following people:
  • Mr. Stephen E. Croskrey, CEO & Chairman (Age 60, Pay $4.27M)
  • Mr. John A. Dowdy III, Chief Financial Officer (Age 48, Pay $282.82k)
  • Mr. Phillip D. Van Trump, Chief Science & Technology Officer (Age 44, Pay $289.53k)
  • Mr. Michael Smith, Chief Operating Officer (Age 52)
  • Russ Zukowski, VP of Corp. Fin.
  • Mr. Scott C. Tuten, Chief Marketing & Sustainability Officer (Age 45)
  • Mr. John T. Moore, Sr. VP of Bus. Devel.

What is Danimer Scientific's stock symbol?

Danimer Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "DNMR."

Who are Danimer Scientific's major shareholders?

Danimer Scientific's stock is owned by a variety of retail and institutional investors. Top institutional investors include Invesco Ltd. (7.03%), BlackRock Inc. (4.56%), Goldman Sachs Group Inc. (1.59%), Heathbridge Capital Management Ltd. (1.15%), Geode Capital Management LLC (1.10%) and Marshall Wace LLP (1.07%).
View institutional ownership trends for Danimer Scientific
.

Which major investors are selling Danimer Scientific stock?

DNMR stock was sold by a variety of institutional investors in the last quarter, including Iridian Asset Management LLC CT, Marshall Wace LLP, New York State Common Retirement Fund, Ionic Capital Management LLC, BlackRock Inc., Caption Management LLC, UBS Group AG, and Graham Capital Management L.P..
View insider buying and selling activity for Danimer Scientific
or view top insider-selling stocks.

Which major investors are buying Danimer Scientific stock?

DNMR stock was acquired by a variety of institutional investors in the last quarter, including Invesco Ltd., Goldman Sachs Group Inc., Capital Investment Advisors LLC, Think Investments LP, Voloridge Investment Management LLC, Millennium Management LLC, Deutsche Bank AG, and Russell Investments Group Ltd..
View insider buying and selling activity for Danimer Scientific
or or view top insider-buying stocks.

How do I buy shares of Danimer Scientific?

Shares of DNMR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Danimer Scientific's stock price today?

One share of DNMR stock can currently be purchased for approximately $12.48.

How much money does Danimer Scientific make?

Danimer Scientific has a market capitalization of $1.25 billion and generates $47.33 million in revenue each year. The company earns $-8.85 million in net income (profit) each year or ($0.91) on an earnings per share basis.

How many employees does Danimer Scientific have?

Danimer Scientific employs 190 workers across the globe.

What is Danimer Scientific's official website?

The official website for Danimer Scientific is danimerscientific.com.

Where are Danimer Scientific's headquarters?

Danimer Scientific is headquartered at 774A Walker Rd, Great Falls VA, 22066.

How can I contact Danimer Scientific?

Danimer Scientific's mailing address is 774A Walker Rd, Great Falls VA, 22066. The company can be reached via phone at 229-243-7075 or via email at [email protected].


This page was last updated on 12/1/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.